反应详情

To a stirred solution of N-tert-butyl-2-(5-(difluoromethoxy)-1-((1-methylazetidin-3-yl)methyl)-1H-indazol-3-yl)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (33 mg, 53.8 μmol) in dichloromethane (2 mL) was added trifluoroacetic acid (1 mL). After stirring at room temperature for 15 h the mixture was concentrated in vacuo then 25 mL of a Jan. 10, 1960 mixture of ammonium hydroxide/methanol/dichloromethane solution was added. After 1 h, the mixture was concentrated in vacuo. Purification by chromatography (silica, 24 g Analogix column, 0-4% methanol containing 10% ammonium hydroxide in dichloromethane) gave 2-[5-difluoromethoxy-1-(1-methyl-azetidin-3-ylmethyl)-1H-indazol-3-yl]-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide (18 mg, 69%). MS (M+H)+=484; 1H NMR (DMSO-d6) δ: 9.07 (s, 1H), 8.39 (s, 1H), 8.21 (d, J=2.3 Hz, 2H), 7.93 (d, J=9.0 Hz, 1H), 7.87 (s, 1H), 7.38-7.46 (m, 2H), 7.20 (s, 1H), 4.76 (d, J=7.3 Hz, 2H), 4.55 (s, 2H), 3.48 (t, J=8.0 Hz, 1H), 2.36 (s, 3H), 1.50 (s, 9H), 1.05 (t, J=7.3 Hz, 2H).

1. concentrationwas concentrated in vacuo
2. addition10, 1960 mixture of ammonium hydroxide/methanol/dichloromethane solution
3. additionwas added
4. waitAfter 1 h
5. concentrationthe mixture was concentrated in vacuo
6. customPurification by chromatography (silica, 24 g Analogix column, 0-4% methanol containing 10% ammonium hydroxide in dichloromethane)